ocata therapeutics inc (OCAT:NASDAQ GM)
Alan C. Shapiro Ph.D.
Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee, Ocata Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 18 board members in 2 different organizations across 1 different industries.|
See Board Relationships
Mr. Alan C. Shapiro Ph.D. serves as The Ivadelle and Theodore Johnson Professor of Banking and Finance in the Department of Finance and Business Economics, Marshall School of Business, University of Southern California, since 1992. Dr. Shapiro served as Chairman of the Department of Finance and Business Economics, University of Southern California, from 1993 to 1998. Prior to joining the University of Southern California, Dr. Shapiro taught as an Assistant Professor ...
33 Locke DrivePhone: 508-756-1212
Marlborough, Massachusetts 01752
Board Members Memberships*
Independent Trustee and Chairman of Audit Committee
Former Director, Chairman of Compensation Committee and Member of Audit Committee
Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
Former Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Carnegie Mellon University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Olav Hellebo||Chief Executive Officer and Director|
ReNeuron Group plc
|Martin M. McGlynn||Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc|
|I. Richard Garr J.D.||Co-Founder, Chief Executive Officer, President, General Counsel and Director|
|Keith Murphy||Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee|
Organovo Holdings, Inc.
|$362.9K||Compensation as of Fiscal Year 2014.|